Washington Drug Letterprovides concise summaries of FDA
regulatory changes and key legislation that affect prescription and OTC
drugs. Each weekly issue brings you up to date on pre-approval and
post-approval issues that directly impact your operation, such as:
electronic submissions, pediatric studies, user fees and NDA
submissions, drug reimportation, post-market surveillance priorities,
GMPs, international harmonization and more.